Cells | Free Full-Text | Mechanisms of Resistance to Anti-CD38 Daratumumab in Multiple Myeloma
The NADase CD38 is induced by factors secreted from senescent cells providing a potential link between senescence and age-related cellular NAD+ decline. - Abstract - Europe PMC
CD38 and Regulation of the Immune Response Cells in Cancer
Increased CD38 expression in human M(LPS + IFN-γ) monocyte-derived... | Download Scientific Diagram
PTIP governs NAD+ metabolism by regulating CD38 expression to drive macrophage inflammation - ScienceDirect
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
Expression of CD38 and Egr2 protein in M0, M1 and M2 macrophages.
Aging-related inflammation driven by cellular senescence enhances NAD consumption via activation of CD38+ pro-inflammatory macrophages | bioRxiv
CD38 Monoclonal Antibody (90), PerCP-eFluor™ 710 (46-0381-82)
M1 Macrophage Flow Cytometry Panel: R&D Systems
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
Novel Markers to Delineate Murine M1 and M2 Macrophages
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
CD38 and other M1 markers in macrophages treated with SASP. (A)... | Download Scientific Diagram
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Mechanism of CD38 via NAD+ in the Development of Non-alcoholic Fatty Liver Disease
CD38 in the age of COVID-19: a medical perspective | Physiological Reviews
Genes | Free Full-Text | Macrophage Polarization in Atherosclerosis
Frontiers | CD38: A Significant Regulator of Macrophage Function
Two Types of Macrophages: M1 and M2 Macrophages - Cusabio
M1 Macrophage-Derived Nanovesicles Potentiate the Anticancer Efficacy of Immune Checkpoint Inhibitors | ACS Nano
Novel Markers to Delineate Murine M1 and M2 Macrophages | PLOS ONE
Discrimination of M1 and M2 macrophages via CD38 and Egr2 flow... | Download Scientific Diagram
